![]() Anatomical and clinical correlation may be necessary to characterize foci of intermediate uptake. SUV is a useful measure for characterizing benign versus malignant lesions. Ga-DOTA TATE uptake in normal and abnormal structures is highly variable in patients with NET. Uptake was significantly higher in malignant lesions than in benign lesions, but an overlap was noted between the groups. A total of 678 lesions (limited to 5 lesions with highest uptake per organ) were included in the analysis, including 127 benign and 54 indeterminate lesions. Mild uptake (2-3.5) was present in the uterus, colon, thyroid, rectum, and skeleton. ![]() Moderate uptake (3.5-7) was present in the prostate, jejunum, pancreas, ileum, and salivary glands. High physiologic uptake (SUVmax > 7) was observed in spleen, renal parenchyma, adrenal glands, pituitary gland, stomach, and liver (in decreasing order). Abnormal uptake was divided into benign, indeterminate, and malignant categories based on imaging characteristic, clinical follow-up, and pathology. and its commercial partner Curium announced today that Detectnet is now included in the National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology Neuroendocrine and Adrenal Tumors, version 1. SUVmean, and SUVmax were measured in 37 normal anatomical structures for each patient. One hundred four consecutively scanned patients (51 men and 53 women mean age, 56.4 years) with confirmed diagnosis of NET underwent PET/CT 1 hour after administration of Ga-DOTA-TATE. Netspot takes 90 minutes total, and patients are on the scanner for only 30 minutes during that time. The Octreoscan takes two days since patients have to be injected, then scanned four hours later and 24 hours later. To analyze the biodistribution of Ga-DOTA-TATE in the normal tissues and uptake in benign, indeterminate, and malignant lesions in a population of patients with known neuroendocrine tumors (NET) using semiquantitative standardized uptake values (SUV) measurements. Whats more, Netspot significantly improves the imaging experience for patients.
0 Comments
Leave a Reply. |